Draupnir Bio
Copenhagen-based biotechnology company
Draupnir Bio has raised €12M across 1 funding round from 5 investors, most recently a Seed round in Jul 2024. Based in Copenhagen, Denmark; active in Healthtech. Data as of 4 Nov 2026.
Copenhagen, Denmarkdraupnir.bio ↗
Total raised
€12M
€12,000,000
Funding rounds
1
Investors
5
distinct backers
Active since
2024-07
latest 2024-07
Funding by year
EUR raised per yearDraupnir Bio — funding by year — interactive chart.
Data table
| Draupnir Bio — funding by year | |
|---|---|
| 2024 | €12M |
Signals
High confidenceRaise-next likelihood16
base rate 44% for Seed
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-07-31 | Seed | €12M | Export and Investment Fund of Denmark (EIFO),Gilde Healthcare,INKEF Capital,MP Healthcare Venture Management,Novo Holdings | View deal → |
Investors
5Related news
Similar companies
same sector, similar size- Hedia€8.7MDenmark · Healthtech
- Freya Biosciences€11MDenmark · Healthtech
- Enduro Genetics€12MDenmark · Healthtech
- Neurescue€10MDenmark · Healthtech
- Embla€10MDenmark · Healthtech
- InProTher€6.0MDenmark · Healthtech
Global coverage: FundingData